nodes	percent_of_prediction	percent_of_DWPC	metapath
Quetiapine—HTR2C—Sorafenib—thyroid cancer	0.0886	0.208	CbGbCtD
Quetiapine—CYP3A7—Sorafenib—thyroid cancer	0.0578	0.136	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.0578	0.136	CbGbCtD
Quetiapine—CYP3A5—Sorafenib—thyroid cancer	0.0433	0.102	CbGbCtD
Quetiapine—CYP2C19—Sorafenib—thyroid cancer	0.035	0.0821	CbGbCtD
Quetiapine—ABCB1—Sorafenib—thyroid cancer	0.0282	0.0662	CbGbCtD
Quetiapine—CYP3A4—Vandetanib—thyroid cancer	0.028	0.0659	CbGbCtD
Quetiapine—CYP2D6—Sorafenib—thyroid cancer	0.0266	0.0624	CbGbCtD
Quetiapine—ABCB1—Doxorubicin—thyroid cancer	0.0171	0.0402	CbGbCtD
Quetiapine—CYP3A4—Sorafenib—thyroid cancer	0.0169	0.0397	CbGbCtD
Quetiapine—CYP2D6—Doxorubicin—thyroid cancer	0.0161	0.0379	CbGbCtD
Quetiapine—CYP3A4—Doxorubicin—thyroid cancer	0.0103	0.0241	CbGbCtD
Quetiapine—H1F0—neck—thyroid cancer	0.00247	0.0553	CbGeAlD
Quetiapine—H1F0—saliva-secreting gland—thyroid cancer	0.00192	0.0431	CbGeAlD
Quetiapine—HTR1E—head—thyroid cancer	0.00176	0.0395	CbGeAlD
Quetiapine—CHRM4—head—thyroid cancer	0.00154	0.0346	CbGeAlD
Quetiapine—HTR7—neck—thyroid cancer	0.00152	0.0341	CbGeAlD
Quetiapine—H1F0—trachea—thyroid cancer	0.00148	0.0333	CbGeAlD
Quetiapine—DRD3—head—thyroid cancer	0.00144	0.0322	CbGeAlD
Quetiapine—CHRM1—saliva-secreting gland—thyroid cancer	0.00139	0.0312	CbGeAlD
Quetiapine—HTR6—head—thyroid cancer	0.00138	0.031	CbGeAlD
Quetiapine—DRD5—head—thyroid cancer	0.00135	0.0302	CbGeAlD
Quetiapine—CHRM3—saliva-secreting gland—thyroid cancer	0.00125	0.028	CbGeAlD
Quetiapine—CHRM5—head—thyroid cancer	0.00121	0.0271	CbGeAlD
Quetiapine—H1F0—thyroid gland—thyroid cancer	0.00117	0.0263	CbGeAlD
Quetiapine—ADRA1B—head—thyroid cancer	0.0011	0.0247	CbGeAlD
Quetiapine—ADRA1D—head—thyroid cancer	0.00108	0.0242	CbGeAlD
Quetiapine—CHRM1—trachea—thyroid cancer	0.00107	0.0241	CbGeAlD
Quetiapine—H1F0—head—thyroid cancer	0.00104	0.0233	CbGeAlD
Quetiapine—DRD1—head—thyroid cancer	0.00103	0.0231	CbGeAlD
Quetiapine—HTR3A—head—thyroid cancer	0.000993	0.0223	CbGeAlD
Quetiapine—HTR2A—neck—thyroid cancer	0.000949	0.0213	CbGeAlD
Quetiapine—HTR7—trachea—thyroid cancer	0.000915	0.0205	CbGeAlD
Quetiapine—ADRA2C—trachea—thyroid cancer	0.000841	0.0189	CbGeAlD
Quetiapine—HTR1B—head—thyroid cancer	0.000833	0.0187	CbGeAlD
Quetiapine—CHRM2—head—thyroid cancer	0.000829	0.0186	CbGeAlD
Quetiapine—HTR1D—head—thyroid cancer	0.000807	0.0181	CbGeAlD
Quetiapine—HTR2C—head—thyroid cancer	0.000799	0.0179	CbGeAlD
Quetiapine—CHRM3—thyroid gland—thyroid cancer	0.000761	0.0171	CbGeAlD
Quetiapine—CHRM1—head—thyroid cancer	0.000754	0.0169	CbGeAlD
Quetiapine—H1F0—lymph node—thyroid cancer	0.000729	0.0163	CbGeAlD
Quetiapine—HRH1—trachea—thyroid cancer	0.000683	0.0153	CbGeAlD
Quetiapine—CHRM3—head—thyroid cancer	0.000675	0.0151	CbGeAlD
Quetiapine—HTR1A—head—thyroid cancer	0.000672	0.0151	CbGeAlD
Quetiapine—ADRA2A—trachea—thyroid cancer	0.000671	0.0151	CbGeAlD
Quetiapine—HTR7—head—thyroid cancer	0.000642	0.0144	CbGeAlD
Quetiapine—ADRA1A—head—thyroid cancer	0.00062	0.0139	CbGeAlD
Quetiapine—DRD2—head—thyroid cancer	0.000607	0.0136	CbGeAlD
Quetiapine—ADRA2C—head—thyroid cancer	0.00059	0.0132	CbGeAlD
Quetiapine—HTR2A—trachea—thyroid cancer	0.000571	0.0128	CbGeAlD
Quetiapine—ADRA2A—thyroid gland—thyroid cancer	0.000531	0.0119	CbGeAlD
Quetiapine—HRH1—head—thyroid cancer	0.00048	0.0108	CbGeAlD
Quetiapine—ADRA2A—head—thyroid cancer	0.000471	0.0106	CbGeAlD
Quetiapine—ADRA2C—lymph node—thyroid cancer	0.000413	0.00927	CbGeAlD
Quetiapine—HTR2A—head—thyroid cancer	0.000401	0.00898	CbGeAlD
Quetiapine—ABCB1—trachea—thyroid cancer	0.000374	0.00839	CbGeAlD
Quetiapine—CYP2D6—head—thyroid cancer	0.000365	0.00818	CbGeAlD
Quetiapine—HRH1—lymph node—thyroid cancer	0.000336	0.00753	CbGeAlD
Quetiapine—ADRA2A—lymph node—thyroid cancer	0.00033	0.0074	CbGeAlD
Quetiapine—Muscular weakness—Epirubicin—thyroid cancer	0.000306	0.000742	CcSEcCtD
Quetiapine—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000306	0.000742	CcSEcCtD
Quetiapine—Cardiac arrest—Doxorubicin—thyroid cancer	0.000305	0.00074	CcSEcCtD
Quetiapine—Dizziness—Sorafenib—thyroid cancer	0.000305	0.00074	CcSEcCtD
Quetiapine—Mood swings—Doxorubicin—thyroid cancer	0.000304	0.000737	CcSEcCtD
Quetiapine—Abdominal distension—Epirubicin—thyroid cancer	0.000302	0.000732	CcSEcCtD
Quetiapine—Ataxia—Doxorubicin—thyroid cancer	0.000302	0.000732	CcSEcCtD
Quetiapine—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000301	0.000729	CcSEcCtD
Quetiapine—Asthma—Epirubicin—thyroid cancer	0.0003	0.000727	CcSEcCtD
Quetiapine—Dysphagia—Epirubicin—thyroid cancer	0.0003	0.000727	CcSEcCtD
Quetiapine—Influenza—Epirubicin—thyroid cancer	0.0003	0.000727	CcSEcCtD
Quetiapine—Dehydration—Doxorubicin—thyroid cancer	0.000299	0.000724	CcSEcCtD
Quetiapine—Eosinophilia—Epirubicin—thyroid cancer	0.000297	0.00072	CcSEcCtD
Quetiapine—ABCB1—thyroid gland—thyroid cancer	0.000296	0.00663	CbGeAlD
Quetiapine—Dry skin—Doxorubicin—thyroid cancer	0.000294	0.000713	CcSEcCtD
Quetiapine—Pancreatitis—Epirubicin—thyroid cancer	0.000294	0.000713	CcSEcCtD
Quetiapine—Vomiting—Sorafenib—thyroid cancer	0.000293	0.000711	CcSEcCtD
Quetiapine—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000293	0.000711	CcSEcCtD
Quetiapine—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000293	0.000711	CcSEcCtD
Quetiapine—Hypokalaemia—Doxorubicin—thyroid cancer	0.000292	0.000708	CcSEcCtD
Quetiapine—Angina pectoris—Epirubicin—thyroid cancer	0.000292	0.000708	CcSEcCtD
Quetiapine—Rash—Sorafenib—thyroid cancer	0.000291	0.000705	CcSEcCtD
Quetiapine—Dermatitis—Sorafenib—thyroid cancer	0.000291	0.000705	CcSEcCtD
Quetiapine—Breast disorder—Doxorubicin—thyroid cancer	0.00029	0.000703	CcSEcCtD
Quetiapine—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000289	0.000701	CcSEcCtD
Quetiapine—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000289	0.000701	CcSEcCtD
Quetiapine—Headache—Sorafenib—thyroid cancer	0.000289	0.000701	CcSEcCtD
Quetiapine—Bronchitis—Epirubicin—thyroid cancer	0.000288	0.000699	CcSEcCtD
Quetiapine—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000287	0.000696	CcSEcCtD
Quetiapine—Gastritis—Doxorubicin—thyroid cancer	0.000284	0.000689	CcSEcCtD
Quetiapine—Muscular weakness—Doxorubicin—thyroid cancer	0.000283	0.000686	CcSEcCtD
Quetiapine—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000283	0.000686	CcSEcCtD
Quetiapine—Dysuria—Epirubicin—thyroid cancer	0.00028	0.00068	CcSEcCtD
Quetiapine—Neutropenia—Epirubicin—thyroid cancer	0.00028	0.00068	CcSEcCtD
Quetiapine—Abdominal distension—Doxorubicin—thyroid cancer	0.000279	0.000677	CcSEcCtD
Quetiapine—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000279	0.000676	CcSEcCtD
Quetiapine—Influenza—Doxorubicin—thyroid cancer	0.000278	0.000673	CcSEcCtD
Quetiapine—Asthma—Doxorubicin—thyroid cancer	0.000278	0.000673	CcSEcCtD
Quetiapine—Dysphagia—Doxorubicin—thyroid cancer	0.000278	0.000673	CcSEcCtD
Quetiapine—Pollakiuria—Epirubicin—thyroid cancer	0.000277	0.000672	CcSEcCtD
Quetiapine—Eosinophilia—Doxorubicin—thyroid cancer	0.000275	0.000666	CcSEcCtD
Quetiapine—Nausea—Sorafenib—thyroid cancer	0.000274	0.000665	CcSEcCtD
Quetiapine—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000274	0.000664	CcSEcCtD
Quetiapine—Weight increased—Epirubicin—thyroid cancer	0.000273	0.000662	CcSEcCtD
Quetiapine—Pancreatitis—Doxorubicin—thyroid cancer	0.000272	0.00066	CcSEcCtD
Quetiapine—Weight decreased—Epirubicin—thyroid cancer	0.000271	0.000658	CcSEcCtD
Quetiapine—Hyperglycaemia—Epirubicin—thyroid cancer	0.000271	0.000656	CcSEcCtD
Quetiapine—Angina pectoris—Doxorubicin—thyroid cancer	0.00027	0.000655	CcSEcCtD
Quetiapine—Pneumonia—Epirubicin—thyroid cancer	0.000269	0.000652	CcSEcCtD
Quetiapine—Infestation NOS—Epirubicin—thyroid cancer	0.000267	0.000648	CcSEcCtD
Quetiapine—Infestation—Epirubicin—thyroid cancer	0.000267	0.000648	CcSEcCtD
Quetiapine—Bronchitis—Doxorubicin—thyroid cancer	0.000267	0.000647	CcSEcCtD
Quetiapine—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000265	0.000643	CcSEcCtD
Quetiapine—ABCB1—head—thyroid cancer	0.000263	0.00589	CbGeAlD
Quetiapine—Jaundice—Epirubicin—thyroid cancer	0.000261	0.000632	CcSEcCtD
Quetiapine—Stomatitis—Epirubicin—thyroid cancer	0.000261	0.000632	CcSEcCtD
Quetiapine—Urinary tract infection—Epirubicin—thyroid cancer	0.00026	0.00063	CcSEcCtD
Quetiapine—Conjunctivitis—Epirubicin—thyroid cancer	0.00026	0.00063	CcSEcCtD
Quetiapine—Neutropenia—Doxorubicin—thyroid cancer	0.00026	0.000629	CcSEcCtD
Quetiapine—Dysuria—Doxorubicin—thyroid cancer	0.00026	0.000629	CcSEcCtD
Quetiapine—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000258	0.000625	CcSEcCtD
Quetiapine—Sweating—Epirubicin—thyroid cancer	0.000256	0.000621	CcSEcCtD
Quetiapine—Pollakiuria—Doxorubicin—thyroid cancer	0.000256	0.000621	CcSEcCtD
Quetiapine—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000253	0.000614	CcSEcCtD
Quetiapine—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000253	0.000613	CcSEcCtD
Quetiapine—Weight increased—Doxorubicin—thyroid cancer	0.000253	0.000612	CcSEcCtD
Quetiapine—Epistaxis—Epirubicin—thyroid cancer	0.000252	0.000611	CcSEcCtD
Quetiapine—Weight decreased—Doxorubicin—thyroid cancer	0.000251	0.000609	CcSEcCtD
Quetiapine—Sinusitis—Epirubicin—thyroid cancer	0.000251	0.000608	CcSEcCtD
Quetiapine—Hyperglycaemia—Doxorubicin—thyroid cancer	0.00025	0.000607	CcSEcCtD
Quetiapine—Agranulocytosis—Epirubicin—thyroid cancer	0.00025	0.000605	CcSEcCtD
Quetiapine—Pneumonia—Doxorubicin—thyroid cancer	0.000249	0.000603	CcSEcCtD
Quetiapine—Infestation NOS—Doxorubicin—thyroid cancer	0.000247	0.0006	CcSEcCtD
Quetiapine—Infestation—Doxorubicin—thyroid cancer	0.000247	0.0006	CcSEcCtD
Quetiapine—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000245	0.000595	CcSEcCtD
Quetiapine—Bradycardia—Epirubicin—thyroid cancer	0.000244	0.000592	CcSEcCtD
Quetiapine—Haemoglobin—Epirubicin—thyroid cancer	0.000241	0.000585	CcSEcCtD
Quetiapine—Jaundice—Doxorubicin—thyroid cancer	0.000241	0.000585	CcSEcCtD
Quetiapine—Stomatitis—Doxorubicin—thyroid cancer	0.000241	0.000585	CcSEcCtD
Quetiapine—Rhinitis—Epirubicin—thyroid cancer	0.000241	0.000583	CcSEcCtD
Quetiapine—Conjunctivitis—Doxorubicin—thyroid cancer	0.000241	0.000583	CcSEcCtD
Quetiapine—Urinary tract infection—Doxorubicin—thyroid cancer	0.000241	0.000583	CcSEcCtD
Quetiapine—Hepatitis—Epirubicin—thyroid cancer	0.00024	0.000582	CcSEcCtD
Quetiapine—Haemorrhage—Epirubicin—thyroid cancer	0.00024	0.000582	CcSEcCtD
Quetiapine—Hypoaesthesia—Epirubicin—thyroid cancer	0.000239	0.000579	CcSEcCtD
Quetiapine—Pharyngitis—Epirubicin—thyroid cancer	0.000238	0.000578	CcSEcCtD
Quetiapine—Sweating—Doxorubicin—thyroid cancer	0.000237	0.000575	CcSEcCtD
Quetiapine—Urinary tract disorder—Epirubicin—thyroid cancer	0.000237	0.000575	CcSEcCtD
Quetiapine—Oedema peripheral—Epirubicin—thyroid cancer	0.000236	0.000573	CcSEcCtD
Quetiapine—Connective tissue disorder—Epirubicin—thyroid cancer	0.000236	0.000572	CcSEcCtD
Quetiapine—Urethral disorder—Epirubicin—thyroid cancer	0.000235	0.00057	CcSEcCtD
Quetiapine—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000234	0.000567	CcSEcCtD
Quetiapine—Epistaxis—Doxorubicin—thyroid cancer	0.000233	0.000566	CcSEcCtD
Quetiapine—Sinusitis—Doxorubicin—thyroid cancer	0.000232	0.000563	CcSEcCtD
Quetiapine—Visual impairment—Epirubicin—thyroid cancer	0.000231	0.000561	CcSEcCtD
Quetiapine—Agranulocytosis—Doxorubicin—thyroid cancer	0.000231	0.00056	CcSEcCtD
Quetiapine—Erythema multiforme—Epirubicin—thyroid cancer	0.000227	0.00055	CcSEcCtD
Quetiapine—Bradycardia—Doxorubicin—thyroid cancer	0.000226	0.000548	CcSEcCtD
Quetiapine—Eye disorder—Epirubicin—thyroid cancer	0.000224	0.000544	CcSEcCtD
Quetiapine—Tinnitus—Epirubicin—thyroid cancer	0.000224	0.000543	CcSEcCtD
Quetiapine—Haemoglobin—Doxorubicin—thyroid cancer	0.000223	0.000541	CcSEcCtD
Quetiapine—Cardiac disorder—Epirubicin—thyroid cancer	0.000223	0.00054	CcSEcCtD
Quetiapine—Rhinitis—Doxorubicin—thyroid cancer	0.000223	0.00054	CcSEcCtD
Quetiapine—Haemorrhage—Doxorubicin—thyroid cancer	0.000222	0.000538	CcSEcCtD
Quetiapine—Hepatitis—Doxorubicin—thyroid cancer	0.000222	0.000538	CcSEcCtD
Quetiapine—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000221	0.000536	CcSEcCtD
Quetiapine—Pharyngitis—Doxorubicin—thyroid cancer	0.00022	0.000534	CcSEcCtD
Quetiapine—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000219	0.000532	CcSEcCtD
Quetiapine—Oedema peripheral—Doxorubicin—thyroid cancer	0.000219	0.00053	CcSEcCtD
Quetiapine—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000218	0.000529	CcSEcCtD
Quetiapine—Angiopathy—Epirubicin—thyroid cancer	0.000218	0.000528	CcSEcCtD
Quetiapine—Urethral disorder—Doxorubicin—thyroid cancer	0.000218	0.000528	CcSEcCtD
Quetiapine—Immune system disorder—Epirubicin—thyroid cancer	0.000217	0.000526	CcSEcCtD
Quetiapine—Mediastinal disorder—Epirubicin—thyroid cancer	0.000216	0.000524	CcSEcCtD
Quetiapine—Chills—Epirubicin—thyroid cancer	0.000215	0.000522	CcSEcCtD
Quetiapine—Visual impairment—Doxorubicin—thyroid cancer	0.000214	0.000519	CcSEcCtD
Quetiapine—Mental disorder—Epirubicin—thyroid cancer	0.00021	0.00051	CcSEcCtD
Quetiapine—Erythema multiforme—Doxorubicin—thyroid cancer	0.00021	0.000509	CcSEcCtD
Quetiapine—Malnutrition—Epirubicin—thyroid cancer	0.000209	0.000507	CcSEcCtD
Quetiapine—Eye disorder—Doxorubicin—thyroid cancer	0.000208	0.000503	CcSEcCtD
Quetiapine—Tinnitus—Doxorubicin—thyroid cancer	0.000207	0.000502	CcSEcCtD
Quetiapine—Cardiac disorder—Doxorubicin—thyroid cancer	0.000206	0.0005	CcSEcCtD
Quetiapine—Flatulence—Epirubicin—thyroid cancer	0.000206	0.000499	CcSEcCtD
Quetiapine—Tension—Epirubicin—thyroid cancer	0.000205	0.000497	CcSEcCtD
Quetiapine—Dysgeusia—Epirubicin—thyroid cancer	0.000205	0.000496	CcSEcCtD
Quetiapine—Nervousness—Epirubicin—thyroid cancer	0.000203	0.000492	CcSEcCtD
Quetiapine—Back pain—Epirubicin—thyroid cancer	0.000202	0.00049	CcSEcCtD
Quetiapine—Angiopathy—Doxorubicin—thyroid cancer	0.000202	0.000489	CcSEcCtD
Quetiapine—Muscle spasms—Epirubicin—thyroid cancer	0.000201	0.000487	CcSEcCtD
Quetiapine—Immune system disorder—Doxorubicin—thyroid cancer	0.000201	0.000486	CcSEcCtD
Quetiapine—Mediastinal disorder—Doxorubicin—thyroid cancer	0.0002	0.000485	CcSEcCtD
Quetiapine—Chills—Doxorubicin—thyroid cancer	0.000199	0.000483	CcSEcCtD
Quetiapine—Vision blurred—Epirubicin—thyroid cancer	0.000197	0.000477	CcSEcCtD
Quetiapine—Mental disorder—Doxorubicin—thyroid cancer	0.000195	0.000472	CcSEcCtD
Quetiapine—Ill-defined disorder—Epirubicin—thyroid cancer	0.000194	0.00047	CcSEcCtD
Quetiapine—Malnutrition—Doxorubicin—thyroid cancer	0.000193	0.000469	CcSEcCtD
Quetiapine—Anaemia—Epirubicin—thyroid cancer	0.000193	0.000468	CcSEcCtD
Quetiapine—Agitation—Epirubicin—thyroid cancer	0.000192	0.000466	CcSEcCtD
Quetiapine—Flatulence—Doxorubicin—thyroid cancer	0.000191	0.000462	CcSEcCtD
Quetiapine—Tension—Doxorubicin—thyroid cancer	0.00019	0.00046	CcSEcCtD
Quetiapine—Dysgeusia—Doxorubicin—thyroid cancer	0.000189	0.000459	CcSEcCtD
Quetiapine—Malaise—Epirubicin—thyroid cancer	0.000188	0.000457	CcSEcCtD
Quetiapine—Nervousness—Doxorubicin—thyroid cancer	0.000188	0.000455	CcSEcCtD
Quetiapine—Vertigo—Epirubicin—thyroid cancer	0.000188	0.000455	CcSEcCtD
Quetiapine—Syncope—Epirubicin—thyroid cancer	0.000187	0.000454	CcSEcCtD
Quetiapine—Leukopenia—Epirubicin—thyroid cancer	0.000187	0.000453	CcSEcCtD
Quetiapine—Back pain—Doxorubicin—thyroid cancer	0.000187	0.000453	CcSEcCtD
Quetiapine—Muscle spasms—Doxorubicin—thyroid cancer	0.000186	0.000451	CcSEcCtD
Quetiapine—Palpitations—Epirubicin—thyroid cancer	0.000185	0.000448	CcSEcCtD
Quetiapine—ABCB1—lymph node—thyroid cancer	0.000184	0.00412	CbGeAlD
Quetiapine—Loss of consciousness—Epirubicin—thyroid cancer	0.000184	0.000445	CcSEcCtD
Quetiapine—Cough—Epirubicin—thyroid cancer	0.000182	0.000442	CcSEcCtD
Quetiapine—Vision blurred—Doxorubicin—thyroid cancer	0.000182	0.000442	CcSEcCtD
Quetiapine—Convulsion—Epirubicin—thyroid cancer	0.000181	0.000439	CcSEcCtD
Quetiapine—Hypertension—Epirubicin—thyroid cancer	0.00018	0.000437	CcSEcCtD
Quetiapine—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000179	0.000435	CcSEcCtD
Quetiapine—Anaemia—Doxorubicin—thyroid cancer	0.000179	0.000433	CcSEcCtD
Quetiapine—Chest pain—Epirubicin—thyroid cancer	0.000178	0.000431	CcSEcCtD
Quetiapine—Arthralgia—Epirubicin—thyroid cancer	0.000178	0.000431	CcSEcCtD
Quetiapine—Myalgia—Epirubicin—thyroid cancer	0.000178	0.000431	CcSEcCtD
Quetiapine—Agitation—Doxorubicin—thyroid cancer	0.000178	0.000431	CcSEcCtD
Quetiapine—Anxiety—Epirubicin—thyroid cancer	0.000177	0.00043	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000177	0.000428	CcSEcCtD
Quetiapine—Discomfort—Epirubicin—thyroid cancer	0.000176	0.000426	CcSEcCtD
Quetiapine—Malaise—Doxorubicin—thyroid cancer	0.000174	0.000423	CcSEcCtD
Quetiapine—Dry mouth—Epirubicin—thyroid cancer	0.000174	0.000422	CcSEcCtD
Quetiapine—Vertigo—Doxorubicin—thyroid cancer	0.000174	0.000421	CcSEcCtD
Quetiapine—Syncope—Doxorubicin—thyroid cancer	0.000173	0.00042	CcSEcCtD
Quetiapine—Leukopenia—Doxorubicin—thyroid cancer	0.000173	0.00042	CcSEcCtD
Quetiapine—Confusional state—Epirubicin—thyroid cancer	0.000172	0.000417	CcSEcCtD
Quetiapine—Palpitations—Doxorubicin—thyroid cancer	0.000171	0.000414	CcSEcCtD
Quetiapine—Anaphylactic shock—Epirubicin—thyroid cancer	0.000171	0.000413	CcSEcCtD
Quetiapine—Loss of consciousness—Doxorubicin—thyroid cancer	0.00017	0.000412	CcSEcCtD
Quetiapine—Infection—Epirubicin—thyroid cancer	0.000169	0.000411	CcSEcCtD
Quetiapine—Cough—Doxorubicin—thyroid cancer	0.000169	0.000409	CcSEcCtD
Quetiapine—Shock—Epirubicin—thyroid cancer	0.000168	0.000407	CcSEcCtD
Quetiapine—Convulsion—Doxorubicin—thyroid cancer	0.000168	0.000406	CcSEcCtD
Quetiapine—Nervous system disorder—Epirubicin—thyroid cancer	0.000167	0.000405	CcSEcCtD
Quetiapine—Thrombocytopenia—Epirubicin—thyroid cancer	0.000167	0.000405	CcSEcCtD
Quetiapine—Hypertension—Doxorubicin—thyroid cancer	0.000167	0.000405	CcSEcCtD
Quetiapine—Tachycardia—Epirubicin—thyroid cancer	0.000166	0.000404	CcSEcCtD
Quetiapine—Skin disorder—Epirubicin—thyroid cancer	0.000166	0.000402	CcSEcCtD
Quetiapine—Hyperhidrosis—Epirubicin—thyroid cancer	0.000165	0.0004	CcSEcCtD
Quetiapine—Arthralgia—Doxorubicin—thyroid cancer	0.000165	0.000399	CcSEcCtD
Quetiapine—Myalgia—Doxorubicin—thyroid cancer	0.000165	0.000399	CcSEcCtD
Quetiapine—Chest pain—Doxorubicin—thyroid cancer	0.000165	0.000399	CcSEcCtD
Quetiapine—Anxiety—Doxorubicin—thyroid cancer	0.000164	0.000398	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000163	0.000396	CcSEcCtD
Quetiapine—Discomfort—Doxorubicin—thyroid cancer	0.000163	0.000394	CcSEcCtD
Quetiapine—Anorexia—Epirubicin—thyroid cancer	0.000163	0.000394	CcSEcCtD
Quetiapine—Dry mouth—Doxorubicin—thyroid cancer	0.000161	0.00039	CcSEcCtD
Quetiapine—Hypotension—Epirubicin—thyroid cancer	0.000159	0.000386	CcSEcCtD
Quetiapine—Confusional state—Doxorubicin—thyroid cancer	0.000159	0.000386	CcSEcCtD
Quetiapine—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000158	0.000383	CcSEcCtD
Quetiapine—Infection—Doxorubicin—thyroid cancer	0.000157	0.00038	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000155	0.000377	CcSEcCtD
Quetiapine—Shock—Doxorubicin—thyroid cancer	0.000155	0.000376	CcSEcCtD
Quetiapine—Nervous system disorder—Doxorubicin—thyroid cancer	0.000155	0.000375	CcSEcCtD
Quetiapine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000155	0.000375	CcSEcCtD
Quetiapine—Insomnia—Epirubicin—thyroid cancer	0.000154	0.000374	CcSEcCtD
Quetiapine—Tachycardia—Doxorubicin—thyroid cancer	0.000154	0.000373	CcSEcCtD
Quetiapine—Skin disorder—Doxorubicin—thyroid cancer	0.000153	0.000372	CcSEcCtD
Quetiapine—Paraesthesia—Epirubicin—thyroid cancer	0.000153	0.000371	CcSEcCtD
Quetiapine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000153	0.00037	CcSEcCtD
Quetiapine—Dyspnoea—Epirubicin—thyroid cancer	0.000152	0.000369	CcSEcCtD
Quetiapine—Somnolence—Epirubicin—thyroid cancer	0.000152	0.000368	CcSEcCtD
Quetiapine—Anorexia—Doxorubicin—thyroid cancer	0.00015	0.000365	CcSEcCtD
Quetiapine—Dyspepsia—Epirubicin—thyroid cancer	0.00015	0.000364	CcSEcCtD
Quetiapine—Decreased appetite—Epirubicin—thyroid cancer	0.000148	0.000359	CcSEcCtD
Quetiapine—Hypotension—Doxorubicin—thyroid cancer	0.000147	0.000357	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000147	0.000357	CcSEcCtD
Quetiapine—Fatigue—Epirubicin—thyroid cancer	0.000147	0.000356	CcSEcCtD
Quetiapine—Pain—Epirubicin—thyroid cancer	0.000146	0.000354	CcSEcCtD
Quetiapine—Constipation—Epirubicin—thyroid cancer	0.000146	0.000354	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000144	0.000349	CcSEcCtD
Quetiapine—Insomnia—Doxorubicin—thyroid cancer	0.000143	0.000346	CcSEcCtD
Quetiapine—Paraesthesia—Doxorubicin—thyroid cancer	0.000142	0.000344	CcSEcCtD
Quetiapine—Dyspnoea—Doxorubicin—thyroid cancer	0.000141	0.000341	CcSEcCtD
Quetiapine—Feeling abnormal—Epirubicin—thyroid cancer	0.000141	0.000341	CcSEcCtD
Quetiapine—Somnolence—Doxorubicin—thyroid cancer	0.00014	0.00034	CcSEcCtD
Quetiapine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000139	0.000338	CcSEcCtD
Quetiapine—Dyspepsia—Doxorubicin—thyroid cancer	0.000139	0.000337	CcSEcCtD
Quetiapine—Decreased appetite—Doxorubicin—thyroid cancer	0.000137	0.000333	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000136	0.00033	CcSEcCtD
Quetiapine—Fatigue—Doxorubicin—thyroid cancer	0.000136	0.00033	CcSEcCtD
Quetiapine—Pain—Doxorubicin—thyroid cancer	0.000135	0.000327	CcSEcCtD
Quetiapine—Constipation—Doxorubicin—thyroid cancer	0.000135	0.000327	CcSEcCtD
Quetiapine—Abdominal pain—Epirubicin—thyroid cancer	0.000135	0.000327	CcSEcCtD
Quetiapine—Body temperature increased—Epirubicin—thyroid cancer	0.000135	0.000327	CcSEcCtD
Quetiapine—Feeling abnormal—Doxorubicin—thyroid cancer	0.00013	0.000315	CcSEcCtD
Quetiapine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000129	0.000313	CcSEcCtD
Quetiapine—Hypersensitivity—Epirubicin—thyroid cancer	0.000126	0.000305	CcSEcCtD
Quetiapine—Abdominal pain—Doxorubicin—thyroid cancer	0.000125	0.000302	CcSEcCtD
Quetiapine—Body temperature increased—Doxorubicin—thyroid cancer	0.000125	0.000302	CcSEcCtD
Quetiapine—Asthenia—Epirubicin—thyroid cancer	0.000122	0.000297	CcSEcCtD
Quetiapine—Pruritus—Epirubicin—thyroid cancer	0.000121	0.000293	CcSEcCtD
Quetiapine—Diarrhoea—Epirubicin—thyroid cancer	0.000117	0.000283	CcSEcCtD
Quetiapine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000116	0.000282	CcSEcCtD
Quetiapine—Asthenia—Doxorubicin—thyroid cancer	0.000113	0.000274	CcSEcCtD
Quetiapine—Dizziness—Epirubicin—thyroid cancer	0.000113	0.000273	CcSEcCtD
Quetiapine—Pruritus—Doxorubicin—thyroid cancer	0.000112	0.000271	CcSEcCtD
Quetiapine—Vomiting—Epirubicin—thyroid cancer	0.000108	0.000263	CcSEcCtD
Quetiapine—Diarrhoea—Doxorubicin—thyroid cancer	0.000108	0.000262	CcSEcCtD
Quetiapine—Rash—Epirubicin—thyroid cancer	0.000108	0.000261	CcSEcCtD
Quetiapine—Dermatitis—Epirubicin—thyroid cancer	0.000107	0.00026	CcSEcCtD
Quetiapine—Headache—Epirubicin—thyroid cancer	0.000107	0.000259	CcSEcCtD
Quetiapine—Dizziness—Doxorubicin—thyroid cancer	0.000104	0.000253	CcSEcCtD
Quetiapine—Nausea—Epirubicin—thyroid cancer	0.000101	0.000246	CcSEcCtD
Quetiapine—Vomiting—Doxorubicin—thyroid cancer	0.0001	0.000243	CcSEcCtD
Quetiapine—Rash—Doxorubicin—thyroid cancer	9.95e-05	0.000241	CcSEcCtD
Quetiapine—Dermatitis—Doxorubicin—thyroid cancer	9.94e-05	0.000241	CcSEcCtD
Quetiapine—Headache—Doxorubicin—thyroid cancer	9.89e-05	0.00024	CcSEcCtD
Quetiapine—Nausea—Doxorubicin—thyroid cancer	9.37e-05	0.000227	CcSEcCtD
Quetiapine—ADRA2C—Signaling by GPCR—KRAS—thyroid cancer	1.27e-05	0.000108	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PPARG—thyroid cancer	1.26e-05	0.000108	CbGpPWpGaD
Quetiapine—DRD1—GPCR downstream signaling—AKT1—thyroid cancer	1.26e-05	0.000107	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—BRAF—thyroid cancer	1.26e-05	0.000107	CbGpPWpGaD
Quetiapine—CHRM4—Signaling by GPCR—AKT1—thyroid cancer	1.25e-05	0.000107	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—KRAS—thyroid cancer	1.25e-05	0.000106	CbGpPWpGaD
Quetiapine—ADRA1D—GPCR downstream signaling—AKT1—thyroid cancer	1.24e-05	0.000106	CbGpPWpGaD
Quetiapine—DRD3—GPCR downstream signaling—AKT1—thyroid cancer	1.24e-05	0.000106	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—BRAF—thyroid cancer	1.24e-05	0.000105	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—BRAF—thyroid cancer	1.23e-05	0.000105	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—PTEN—thyroid cancer	1.23e-05	0.000105	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—BRAF—thyroid cancer	1.23e-05	0.000105	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—BRAF—thyroid cancer	1.22e-05	0.000105	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—NRAS—thyroid cancer	1.21e-05	0.000104	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—CCND1—thyroid cancer	1.21e-05	0.000104	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—BRAF—thyroid cancer	1.21e-05	0.000104	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—NRAS—thyroid cancer	1.21e-05	0.000104	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—BRAF—thyroid cancer	1.21e-05	0.000103	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—NRAS—thyroid cancer	1.2e-05	0.000103	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—TP53—thyroid cancer	1.2e-05	0.000103	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—PTEN—thyroid cancer	1.2e-05	0.000102	CbGpPWpGaD
Quetiapine—CHRM5—Signaling by GPCR—AKT1—thyroid cancer	1.2e-05	0.000102	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—CCND1—thyroid cancer	1.2e-05	0.000102	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—CCND1—thyroid cancer	1.2e-05	0.000102	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—NRAS—thyroid cancer	1.2e-05	0.000102	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—PTGS2—thyroid cancer	1.18e-05	0.000101	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—NRAS—thyroid cancer	1.18e-05	0.000101	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—PTEN—thyroid cancer	1.17e-05	0.0001	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—PTEN—thyroid cancer	1.17e-05	9.95e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—NRAS—thyroid cancer	1.16e-05	9.91e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—PTEN—thyroid cancer	1.16e-05	9.87e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—PTEN—thyroid cancer	1.16e-05	9.87e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling by GPCR—HRAS—thyroid cancer	1.15e-05	9.84e-05	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—HRAS—thyroid cancer	1.15e-05	9.82e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—KRAS—thyroid cancer	1.15e-05	9.81e-05	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—AKT1—thyroid cancer	1.15e-05	9.8e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—NRAS—thyroid cancer	1.15e-05	9.78e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling by GPCR—AKT1—thyroid cancer	1.14e-05	9.75e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—KRAS—thyroid cancer	1.13e-05	9.66e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—KRAS—thyroid cancer	1.13e-05	9.63e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling by GPCR—AKT1—thyroid cancer	1.13e-05	9.62e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling by GPCR—AKT1—thyroid cancer	1.13e-05	9.62e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—KRAS—thyroid cancer	1.13e-05	9.6e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—BRAF—thyroid cancer	1.12e-05	9.59e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—KRAS—thyroid cancer	1.12e-05	9.57e-05	CbGpPWpGaD
Quetiapine—ADRA2B—GPCR downstream signaling—AKT1—thyroid cancer	1.12e-05	9.57e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling by GPCR—HRAS—thyroid cancer	1.11e-05	9.5e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—KRAS—thyroid cancer	1.11e-05	9.48e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.11e-05	9.46e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—KRAS—thyroid cancer	1.11e-05	9.45e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—HRAS—thyroid cancer	1.11e-05	9.45e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—NRAS—thyroid cancer	1.1e-05	9.36e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—PTGS2—thyroid cancer	1.09e-05	9.27e-05	CbGpPWpGaD
Quetiapine—HTR1A—GPCR downstream signaling—AKT1—thyroid cancer	1.08e-05	9.24e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—CCND1—thyroid cancer	1.08e-05	9.23e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—HRAS—thyroid cancer	1.08e-05	9.19e-05	CbGpPWpGaD
Quetiapine—HTR2C—GPCR downstream signaling—AKT1—thyroid cancer	1.08e-05	9.19e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—HRAS—thyroid cancer	1.06e-05	9.05e-05	CbGpPWpGaD
Quetiapine—ADRA2C—GPCR downstream signaling—AKT1—thyroid cancer	1.05e-05	8.94e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—NRAS—thyroid cancer	1.04e-05	8.92e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—KRAS—thyroid cancer	1.04e-05	8.92e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—KRAS—thyroid cancer	1.04e-05	8.91e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—CCND1—thyroid cancer	1.04e-05	8.91e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—PTEN—thyroid cancer	1.04e-05	8.91e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—CCND1—thyroid cancer	1.04e-05	8.86e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—KRAS—thyroid cancer	1.04e-05	8.85e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—PTEN—thyroid cancer	1.03e-05	8.81e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—NRAS—thyroid cancer	1.03e-05	8.8e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—NRAS—thyroid cancer	1.03e-05	8.8e-05	CbGpPWpGaD
Quetiapine—ADRA1B—GPCR downstream signaling—AKT1—thyroid cancer	1.03e-05	8.8e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—KRAS—thyroid cancer	1.03e-05	8.78e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling by GPCR—AKT1—thyroid cancer	1.02e-05	8.69e-05	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—AKT1—thyroid cancer	1.02e-05	8.67e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—KRAS—thyroid cancer	1.02e-05	8.67e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—CCND1—thyroid cancer	1.01e-05	8.62e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—PTEN—thyroid cancer	1.01e-05	8.6e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—PTEN—thyroid cancer	1e-05	8.55e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—KRAS—thyroid cancer	9.99e-06	8.53e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PTGS2—thyroid cancer	9.95e-06	8.49e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—CCND1—thyroid cancer	9.94e-06	8.48e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—KRAS—thyroid cancer	9.86e-06	8.41e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling by GPCR—AKT1—thyroid cancer	9.83e-06	8.39e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PPARG—thyroid cancer	9.78e-06	8.35e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—AKT1—thyroid cancer	9.78e-06	8.34e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—HRAS—thyroid cancer	9.77e-06	8.34e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—PTEN—thyroid cancer	9.75e-06	8.32e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—HRAS—thyroid cancer	9.61e-06	8.21e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—HRAS—thyroid cancer	9.59e-06	8.19e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—PTEN—thyroid cancer	9.59e-06	8.19e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—HRAS—thyroid cancer	9.56e-06	8.16e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PPARG—thyroid cancer	9.54e-06	8.15e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—HRAS—thyroid cancer	9.53e-06	8.14e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—AKT1—thyroid cancer	9.51e-06	8.12e-05	CbGpPWpGaD
Quetiapine—DRD2—GPCR downstream signaling—AKT1—thyroid cancer	9.5e-06	8.11e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—PTEN—thyroid cancer	9.47e-06	8.08e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—HRAS—thyroid cancer	9.44e-06	8.06e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—KRAS—thyroid cancer	9.44e-06	8.06e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—HRAS—thyroid cancer	9.41e-06	8.04e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—AKT1—thyroid cancer	9.36e-06	7.99e-05	CbGpPWpGaD
Quetiapine—HTR2A—GPCR downstream signaling—AKT1—thyroid cancer	9.35e-06	7.98e-05	CbGpPWpGaD
Quetiapine—HRH1—GPCR downstream signaling—AKT1—thyroid cancer	9.33e-06	7.96e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—RXRA—thyroid cancer	9.31e-06	7.95e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—NRAS—thyroid cancer	9.31e-06	7.95e-05	CbGpPWpGaD
Quetiapine—CHRM1—GPCR downstream signaling—AKT1—thyroid cancer	9.3e-06	7.94e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—TP53—thyroid cancer	9.29e-06	7.93e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—TP53—thyroid cancer	9.28e-06	7.92e-05	CbGpPWpGaD
Quetiapine—CHRM3—GPCR downstream signaling—AKT1—thyroid cancer	9.27e-06	7.91e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—TP53—thyroid cancer	9.22e-06	7.87e-05	CbGpPWpGaD
Quetiapine—CHRM2—GPCR downstream signaling—AKT1—thyroid cancer	9.18e-06	7.84e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CCND1—thyroid cancer	9.16e-06	7.82e-05	CbGpPWpGaD
Quetiapine—ADRA1A—GPCR downstream signaling—AKT1—thyroid cancer	9.15e-06	7.81e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—TP53—thyroid cancer	9.02e-06	7.7e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CCND1—thyroid cancer	9.02e-06	7.7e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CCND1—thyroid cancer	9e-06	7.68e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—KRAS—thyroid cancer	8.99e-06	7.68e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PPARG—thyroid cancer	8.99e-06	7.68e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—NRAS—thyroid cancer	8.99e-06	7.67e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CCND1—thyroid cancer	8.97e-06	7.65e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—NRAS—thyroid cancer	8.94e-06	7.63e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CCND1—thyroid cancer	8.94e-06	7.63e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—HRAS—thyroid cancer	8.88e-06	7.58e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—TP53—thyroid cancer	8.88e-06	7.58e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—KRAS—thyroid cancer	8.87e-06	7.58e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—KRAS—thyroid cancer	8.87e-06	7.58e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—HRAS—thyroid cancer	8.87e-06	7.57e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CCND1—thyroid cancer	8.85e-06	7.56e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—PTEN—thyroid cancer	8.84e-06	7.55e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CCND1—thyroid cancer	8.83e-06	7.54e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—HRAS—thyroid cancer	8.81e-06	7.52e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—TP53—thyroid cancer	8.76e-06	7.48e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—HRAS—thyroid cancer	8.75e-06	7.47e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—PTEN—thyroid cancer	8.7e-06	7.43e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—NRAS—thyroid cancer	8.7e-06	7.42e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—PTEN—thyroid cancer	8.68e-06	7.41e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PTEN—thyroid cancer	8.68e-06	7.41e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—PTEN—thyroid cancer	8.65e-06	7.39e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—HRAS—thyroid cancer	8.63e-06	7.37e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—AKT1—thyroid cancer	8.63e-06	7.36e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—PTEN—thyroid cancer	8.63e-06	7.36e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—NRAS—thyroid cancer	8.56e-06	7.31e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—PTEN—thyroid cancer	8.54e-06	7.29e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—PTEN—thyroid cancer	8.52e-06	7.27e-05	CbGpPWpGaD
Quetiapine—ADRA2A—GPCR downstream signaling—AKT1—thyroid cancer	8.5e-06	7.26e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—HRAS—thyroid cancer	8.49e-06	7.25e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—AKT1—thyroid cancer	8.49e-06	7.25e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—AKT1—thyroid cancer	8.47e-06	7.23e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—AKT1—thyroid cancer	8.44e-06	7.21e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—AKT1—thyroid cancer	8.42e-06	7.18e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—TP53—thyroid cancer	8.39e-06	7.16e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—HRAS—thyroid cancer	8.38e-06	7.15e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—AKT1—thyroid cancer	8.33e-06	7.12e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—AKT1—thyroid cancer	8.31e-06	7.1e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CCND1—thyroid cancer	8.2e-06	7e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—HRAS—thyroid cancer	8.02e-06	6.85e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—KRAS—thyroid cancer	8.01e-06	6.84e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—TP53—thyroid cancer	7.99e-06	6.82e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—PTEN—thyroid cancer	7.92e-06	6.76e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—NRAS—thyroid cancer	7.89e-06	6.74e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—TP53—thyroid cancer	7.89e-06	6.73e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—TP53—thyroid cancer	7.89e-06	6.73e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—AKT1—thyroid cancer	7.84e-06	6.69e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—AKT1—thyroid cancer	7.83e-06	6.69e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—AKT1—thyroid cancer	7.78e-06	6.64e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—NRAS—thyroid cancer	7.76e-06	6.63e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—NRAS—thyroid cancer	7.75e-06	6.61e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—KRAS—thyroid cancer	7.73e-06	6.6e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—AKT1—thyroid cancer	7.72e-06	6.59e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—NRAS—thyroid cancer	7.72e-06	6.59e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—NRAS—thyroid cancer	7.7e-06	6.57e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—KRAS—thyroid cancer	7.69e-06	6.57e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PTGS2—thyroid cancer	7.69e-06	6.57e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—HRAS—thyroid cancer	7.64e-06	6.53e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—NRAS—thyroid cancer	7.62e-06	6.51e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—AKT1—thyroid cancer	7.62e-06	6.5e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—NRAS—thyroid cancer	7.6e-06	6.49e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—HRAS—thyroid cancer	7.54e-06	6.44e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—HRAS—thyroid cancer	7.54e-06	6.44e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PTGS2—thyroid cancer	7.51e-06	6.41e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—AKT1—thyroid cancer	7.5e-06	6.4e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—KRAS—thyroid cancer	7.48e-06	6.39e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—AKT1—thyroid cancer	7.4e-06	6.31e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—KRAS—thyroid cancer	7.37e-06	6.29e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—TP53—thyroid cancer	7.12e-06	6.08e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—AKT1—thyroid cancer	7.08e-06	6.05e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PTGS2—thyroid cancer	7.07e-06	6.04e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—NRAS—thyroid cancer	7.06e-06	6.03e-05	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—AKT1—thyroid cancer	6.92e-06	5.9e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—TP53—thyroid cancer	6.87e-06	5.87e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—TP53—thyroid cancer	6.84e-06	5.84e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—HRAS—thyroid cancer	6.81e-06	5.81e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—KRAS—thyroid cancer	6.79e-06	5.8e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—AKT1—thyroid cancer	6.75e-06	5.76e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—AKT1—thyroid cancer	6.72e-06	5.73e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PTEN—thyroid cancer	6.71e-06	5.73e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—KRAS—thyroid cancer	6.68e-06	5.7e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—KRAS—thyroid cancer	6.67e-06	5.69e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—AKT1—thyroid cancer	6.66e-06	5.69e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—AKT1—thyroid cancer	6.66e-06	5.69e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—TP53—thyroid cancer	6.65e-06	5.68e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—KRAS—thyroid cancer	6.65e-06	5.67e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—KRAS—thyroid cancer	6.62e-06	5.66e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—HRAS—thyroid cancer	6.57e-06	5.61e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—KRAS—thyroid cancer	6.56e-06	5.6e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PTEN—thyroid cancer	6.55e-06	5.59e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—TP53—thyroid cancer	6.55e-06	5.59e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—KRAS—thyroid cancer	6.54e-06	5.58e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—HRAS—thyroid cancer	6.54e-06	5.58e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—HRAS—thyroid cancer	6.36e-06	5.43e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—HRAS—thyroid cancer	6.26e-06	5.34e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PTEN—thyroid cancer	6.17e-06	5.27e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—KRAS—thyroid cancer	6.08e-06	5.19e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—TP53—thyroid cancer	6.04e-06	5.15e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—AKT1—thyroid cancer	6.01e-06	5.13e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—AKT1—thyroid cancer	5.95e-06	5.08e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—TP53—thyroid cancer	5.94e-06	5.07e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—TP53—thyroid cancer	5.93e-06	5.06e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—TP53—thyroid cancer	5.91e-06	5.04e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—TP53—thyroid cancer	5.89e-06	5.03e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PPARG—thyroid cancer	5.88e-06	5.02e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—TP53—thyroid cancer	5.83e-06	4.98e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—TP53—thyroid cancer	5.81e-06	4.96e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—AKT1—thyroid cancer	5.8e-06	4.96e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—AKT1—thyroid cancer	5.77e-06	4.93e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—HRAS—thyroid cancer	5.77e-06	4.93e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—HRAS—thyroid cancer	5.68e-06	4.85e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—HRAS—thyroid cancer	5.67e-06	4.84e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—HRAS—thyroid cancer	5.65e-06	4.82e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—HRAS—thyroid cancer	5.63e-06	4.81e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—AKT1—thyroid cancer	5.62e-06	4.79e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—HRAS—thyroid cancer	5.58e-06	4.76e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—HRAS—thyroid cancer	5.56e-06	4.75e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—AKT1—thyroid cancer	5.53e-06	4.72e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—AKT1—thyroid cancer	5.46e-06	4.66e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TP53—thyroid cancer	5.4e-06	4.61e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—HRAS—thyroid cancer	5.17e-06	4.41e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—AKT1—thyroid cancer	5.1e-06	4.35e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—AKT1—thyroid cancer	5.01e-06	4.28e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—AKT1—thyroid cancer	5e-06	4.27e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—AKT1—thyroid cancer	5e-06	4.27e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—AKT1—thyroid cancer	4.99e-06	4.26e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—AKT1—thyroid cancer	4.97e-06	4.24e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—AKT1—thyroid cancer	4.92e-06	4.2e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—AKT1—thyroid cancer	4.91e-06	4.19e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PTGS2—thyroid cancer	4.63e-06	3.95e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—AKT1—thyroid cancer	4.56e-06	3.89e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PTEN—thyroid cancer	4.03e-06	3.44e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—AKT1—thyroid cancer	3.87e-06	3.3e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—AKT1—thyroid cancer	3.77e-06	3.22e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—AKT1—thyroid cancer	3.56e-06	3.04e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—AKT1—thyroid cancer	2.32e-06	1.98e-05	CbGpPWpGaD
